• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.52% Nasdaq Down 0.25%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    119.60 Up 1.74(1.48%) Aug 3, 4:00PM EDT
    |After Hours : 119.50 Down 0.10 (0.08%) Aug 3, 7:53PM EDT
    Add to Portfolio
    Prev Close:117.86
    Open:118.64
    Bid:119.60 x 600
    Ask:120.00 x 700
    1y Target Est:128.21
    Beta:0.88
    Earnings Date:Oct 26 - Oct 30 (Est.)
    Day's Range:118.18 - 120.17
    52wk Range:85.95 - 123.37
    Volume:11,659,988
    Avg Vol (3m):10,929,400
    Market Cap:175.77B
    P/E (ttm):13.64
    EPS (ttm):8.77
    Div & Yield:1.72 (1.50%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GILDUp 1.48%175.77B
    GSKUp 0.16%105.08B
    PFEUp 0.25%222.60B
    RHHBYDown 0.44%244.82B

    Key Statistics

    Forward P/E (1 yr):10.43
    P/S (ttm):6.30
    Ex-Dividend Date:12-Jun-15

    Analysts

    Annual EPS Est (Dec-15) :11.47
    Quarterly EPS Est (Sep-15) :2.81
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):0.49

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical need in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback